Featured Press Releases

Cold Box Express, Inc. Introduces Refreshed Brand

Cold Box Express, Inc. Introduces Refreshed Brand

Fresenius Expands Biosimilars Portfolio with Denosumab Launch in the U.S

Fresenius Expands Biosimilars Portfolio with Denosumab Launch in the U.S

  • 01 Jul 2025

Fresenius announced that its operating company Fresenius Kabi, has introduced two new biosimilars...

Netstal showcases a medtech application with quality monitoring at Fakuma

Netstal showcases a medtech application with quality monitoring at Fakuma

Enhancing Preclinical Research Support, SoBran, Inc. Expands BioScience Services to Los Angeles

Enhancing Preclinical Research Support, SoBran, Inc. Expands BioScience Services to Los Angeles

Epia Neuro Launches Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

Epia Neuro Launches Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

Triquetra Health Launched BioActive Vitamin B1™—the First Complete B1 Activation System with a 600 mg Research-Matched Dose and Full Cofactor Support

Triquetra Health Launched BioActive Vitamin B1™—the First Complete B1 Activation System with a 600 mg Research-Matched Dose and Full Cofactor Support

  • Triquetra Health LLC
  • 03 Aug 2026
Dallas-Based Microbiome Brand resbiotic® Comes Home to Texas with Launch at H-E-B

Dallas-Based Microbiome Brand resbiotic® Comes Home to Texas with Launch at H-E-B

  • Resbiotic Nutrition, Inc.
  • 03 Aug 2026
US Capital Global Securities Announces $20 Million Offering for Thplasma to Invest in the Future of Plasma Therapeutics

US Capital Global Securities Announces $20 Million Offering for Thplasma to Invest in the Future of Plasma Therapeutics

  • US Capital Global
  • 03 Aug 2026
Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection in two single-dose vial strengths

Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection in two single-dose vial strengths

  • Glenmark Pharmaceuticals
  • 30 Jul 2026
EMS and BD expand access to GLP-1 therapies in Brazil by launching semaglutide.

EMS and BD expand access to GLP-1 therapies in Brazil by launching semaglutide.

  • BD (Becton, Dickinson and Company)
  • 29 Jul 2026
Excedr Secures $25 Million in Growth Capital to Expand Its Life Sciences Equipment Leasing Platform

Excedr Secures $25 Million in Growth Capital to Expand Its Life Sciences Equipment Leasing Platform

  • Excedr
  • 28 Jul 2026
The Digital Pharma Advances Conference 2026

Most Popular
August   2026
M T W T F S S
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31            

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.